New drugs for pancreatic cancer

Victoza Pancreatic Cancer / Byetta Pancreatic Cancer / Januvia Pancreatic Cancer Recent reports by the US Food and Drug Administration have raised concern.

pancreatic and other cancers. Patrick Sung, DPhil, director drug development for new and less-toxic treatments for childhood cancers.

The incidence of pancreatic cancer is rising, and some reports project that the number of new pancreatic cancer cases and pancreatic cancer deaths will more than double by 2024. Pancreatic ductal adenocarcinoma (PDA) accounts for more than 90% of pancreatic cancer cases.

A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current

Let's start with pancreatic cancer, what's new in cancer treatment? There treatment, particularly in choosing [chemotherapy] drugs. What is the

According to the National Cancer Institute, pancreatic cancer accounts for 3.2% of all new cancer cases, but it causes nearly 8% of all cancer deaths. And the five-year survival rate for pancreatic cancer is just 10.8%. Here are five things everyone should know about this deadly cancer: Pancreatic cancer is aggressive and causes nonspecific

A new drug candidate permanently modifies a wily cancer-causing mutation, paving the way for making pancreatic cancer treatable

A new drug candidate permanently modifies a wily cancer-causing mutation, paving the way for making pancreatic cancer treatable

NEW: Pancreatitis and pancreatic cancer. Guest Edited by Rupjyoti Talukdar omeprazole in symptomatic treatment of moderate gastroesophageal reflux.